Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | ALPL | P05186 | 1/20 | 0.64 |
| ▸ | ALPI | P09923 | 1/20 | 0.64 |
| ▸ | ALPG | P10696 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | PLEC | Q15149 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 15/20 | 0.58 |
| ▸ | CA1 | P00915 | 13/20 | 0.58 |
| ▸ | CA2 | P00918 | 13/20 | 0.58 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.56 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12045940 | 0.92 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL12900563 | 0.89 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL12231697 | 0.87 | CA9 (0.75) | USP2L3MBTL1CA9CA1CA2 | |
| SCHEMBL1437042 | 0.87 | USP2 (0.78) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20254033 | 0.87 | USP2 (0.77) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14646715 | 0.87 | USP2 (0.61) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL173061 | 0.87 | USP2 (0.73) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL3481432 | 0.86 | USP2 (1.00) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL30023431 | 0.86 | USP2 (1.00) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL18239274 | 0.86 | USP2 (0.76) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294811-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES | SONY GROUP CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3455299-B1 | COMPOSITIONS COMPRISING A POLYMERIC DYE AND A CYCLODEXTRIN AND USES THEREOF | SONY GROUP CORP (JP) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023242661-A2 | POLYMERIC TANDEM DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-12-21 | — | — | WO | disclosed |
| EP-4137818-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | Sony Group Corporation (JP) | 2023-02-22 | — | — | EP | disclosed |
| EP-3222617-B1 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | UNIV JOHNS HOPKINS (US) | 2022-07-06 | — | — | EP | disclosed |
| US-20210109104-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | Sony Group Corporation (JP) | 2021-04-15 | — | — | US | disclosed |
| WO-2021067483-A1 | NUCLEOTIDE PROBES | SONY CORPORATION (JP) | 2021-04-08 | — | — | WO | disclosed |
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | THE BROAD INSTITUTE, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| WO-2019182765-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY CORPORATION (JP) | 2019-09-26 | — | — | WO | disclosed |
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | BROAD INST INC (US) | 2018-06-07 | — | — | US | disclosed |
| US-20110229980-A1 | OLIGONUCLEOTIDE PROBE AND USE THEREOF | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110105496-A1 | Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds | GILEAD COLORADO, INC. | 2011-05-05 | — | — | US | disclosed |
| WO-2011018611-A1 | REVERSIBLE COVALENT LINKAGE OF FUNCTIONAL MOLECULES | UCL BUSINESS PLC (GB) | 2011-02-17 | — | — | WO | disclosed |
| WO-2010097604-A2 | NEW COMPOUNDS | UCL BUSINESS PLC (GB) | 2010-09-02 | — | — | WO | disclosed |
| WO-2009132310-A1 | INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE THWART MYCOBACTERIAL GROWTH | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-10-29 | — | — | WO | disclosed |
| US-7527928-B2 | Reactions on a solid surface | THIRD WAVE TECHNOLOGIES, INC. (US) | 2009-05-05 | — | — | US | disclosed |
| WO-2009027679-A1 | PROCESS FOR THE PREPARATION OF GUANIDINO SUBSTITUTED BI-AND POLYPHENYLS THAT ARE SUITABLE AS SMALL MOLECULE CARRIERS | UCL BUSINESS PLC (GB) | 2009-03-05 | — | — | WO | disclosed |
| US-20080221305-A1 | Polynucleotides encoding novel adiponectin receptor variants | BRISTOL-MYERS SQUIBB COMPANY | 2008-09-11 | — | — | US | disclosed |
| US-7312086-B2 | Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-12-25 | — | — | US | disclosed |
| EP-1084269-B1 | NOVEL PEROXIDASE SUBSTRATES AND THEIR USE IN CATALYZED REPORTER DEPOSITION | PERKINELMER LAS INC (US) | 2007-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221305-A1 | Polynucleotides encoding novel adiponectin receptor variants | ADIPOR1, ADIPOR2, FABP4 | USP2 4016/4885L3MBTL1 3518/4885MEN1 3728/4885 |
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | KDM1A, MAN2B1, KDM3A | USP2 619/4885L3MBTL1 242/4885MEN1 536/4885 |
| US-20110229980-A1 | OLIGONUCLEOTIDE PROBE AND USE THEREOF | DCLRE1B, NSUN2, MTX2 | USP2 2107/4885L3MBTL1 28/4885MEN1 2002/4885 |
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | KDM1A, MAN2B1, KDM3A | USP2 619/4885L3MBTL1 242/4885MEN1 536/4885 |
| US-20110105496-A1 | Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds | MYH2, MYLK2, TNNI3 | USP2 2470/4885L3MBTL1 2800/4885MEN1 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.